A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia
File(s)Savvopoulos_et_al_ModellingFramework.pdf (4.12 MB)
Accepted version
Author(s)
Savvopoulos, S
Misener, R
Panoskaltsis, N
Pistikopoulos, EN
Mantalaris, A
Type
Journal Article
Abstract
Chronic Lymphocytic Leukemia (CLL) is the
most common peripheral blood and bone marrow cancer
in the developed world. This manuscript proposes
mathematical model equations representing the disease
dynamics of B-cell CLL. We interconnect delay differential
cell cycle models in each of the tumor-involved disease
centers using physiologically-relevant cell migration. We
further introduce 5 hypothetical case studies representing
CLL heterogeneity commonly seen in clinical practice
and demonstrate how the proposed CLL model framework
may capture disease pathophysiology across patient
types. We conclude by exploring the capacity of the
proposed temporally- and spatially-distributed model to
capture the heterogeneity of CLL disease progression. By
using Global Sensitivity Analysis, the critical parameters
influencing disease trajectory over space and time are:
(i) the initial number of CLL cells in peripheral blood,
the number of involved lymph nodes, the presence and
degree of splenomegaly; (ii) the migratory fraction of nonproliferating
as well as proliferating CLL cells from bone
marrow into blood and of proliferating CLL cells from
blood into lymph nodes; (iii) the parameters inducing nonproliferative
cells to proliferate. The proposed model offers
a practical platform which may be explored in future
personalized patient protocols once validated.
most common peripheral blood and bone marrow cancer
in the developed world. This manuscript proposes
mathematical model equations representing the disease
dynamics of B-cell CLL. We interconnect delay differential
cell cycle models in each of the tumor-involved disease
centers using physiologically-relevant cell migration. We
further introduce 5 hypothetical case studies representing
CLL heterogeneity commonly seen in clinical practice
and demonstrate how the proposed CLL model framework
may capture disease pathophysiology across patient
types. We conclude by exploring the capacity of the
proposed temporally- and spatially-distributed model to
capture the heterogeneity of CLL disease progression. By
using Global Sensitivity Analysis, the critical parameters
influencing disease trajectory over space and time are:
(i) the initial number of CLL cells in peripheral blood,
the number of involved lymph nodes, the presence and
degree of splenomegaly; (ii) the migratory fraction of nonproliferating
as well as proliferating CLL cells from bone
marrow into blood and of proliferating CLL cells from
blood into lymph nodes; (iii) the parameters inducing nonproliferative
cells to proliferate. The proposed model offers
a practical platform which may be explored in future
personalized patient protocols once validated.
Date Issued
2016-02-24
Date Acceptance
2016-02-19
Citation
IEEE Transactions on Biomedical Engineering, 2016, 63 (11), pp.2396-2404
ISSN
1558-2531
Publisher
Institute of Electrical and Electronics Engineers (IEEE)
Start Page
2396
End Page
2404
Journal / Book Title
IEEE Transactions on Biomedical Engineering
Volume
63
Issue
11
Copyright Statement
© 2016 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.
Sponsor
Royal Academy Of Engineering
Commission of the European Communities
Imperial College Trust
Grant Number
10216/118
340719
N/A
Subjects
Biomedical Engineering
0903 Biomedical Engineering
0906 Electrical And Electronic Engineering
0801 Artificial Intelligence And Image Processing
Publication Status
Published